naltrexone

(redirected from Revia)
Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to Revia: Vivitrol

naltrexone

 [nal-trek´sōn]
an opioid antagonist used as the hydrochloride salt in treatment of opioid or alcohol abuse.

nal·trex·one

(nal-treks'ōn),
An orally active narcotic antagonist; devoid of pharmacologic action when administered in the absence of narcotics.

naltrexone

/nal·trex·one/ (nal-trek´sōn) an opioid antagonist used as the hydrochloride salt in treatment of opioid or alcohol abuse.

naltrexone

(năl-trĕk′sōn)
n.
A synthetic opioid antagonist, C20H23NO4, used in its hydrochloride form to treat addiction to alcohol and to opioid drugs such as heroin.

naltrexone

Substance abuse An opioid antagonist used to manage opiate, alcohol and other abuse substances; naltrexone binds to endorphin receptors, preventing endophin receptor binding, reducing the craving for abuse substances. See Cocaine. Cf Antabuse.

naltrexone

A narcotic antagonist used as a maintenance therapy in former narcotic addicts. A brand name is Nalorex.

naltrexone (nal·trekˑ·sōn),

n a pharmacologic substance that increases the body's production of endorphins; used in treating narcotic addiction.

nal·trex·one

(nal-treks'ōn)
Orally active narcotic antagonist; devoid of pharmacologic action when administered in absence of narcotics.

naltrexone

an opiate antagonist similar to naloxone but with longer action and greater potency.
References in periodicals archive ?
Although this formulation is correct for many segolta clauses, it does not take into account those cases where revia converts to zarqa or (in a few cases) pasta.
His concept of near and far subordinate segments, for one thing, represents a useful analytical tool, because it does capture critical generalizations about the function of certain subordinate disjunctives, such as prose tevir, zarqa, pasta, revia, and "disappearing" poetic revia mugras.
Study Confirms the Safety and Efficacy Profile of REVIA When Used
June 23 /PRNewswire/ -- A multi-center (272 sites), open label observational trial of DuPont Merck's REVIA, an opioid antagonist, showed the medication to be safe, generally well tolerated and effective in the treatment of alcohol dependence as part of an overall treatment program.
Controlled clinical studies conducted by DuPont Pharma involving a combination of ReVia and counseling similar to OMNI's treatment protocol resulted in significant reduction in the craving for alcohol, increased abstinence and increased clinical success.
The study confirmed the safety profile of REVIA in a diverse group of patients including those often excluded from research studies.
David Smith, president and founder of the Haight Ashbury Free Clinics in San Francisco and a former president of the American Society of Addiction Medicine, said, "This study proves REVIA is a clinically useful medication that can bridge the gap that exists between pharmacotherapy and psychosocial treatment modalities to increase the retention rate of alcoholic patients in treatment.
REVIA (naltrexone hydrochloride tablets)* is an opioid antagonist indicated in the treatment of alcohol or opioid dependence as part of a treatment program.
Naltrexone HCI is an oral medication manufactured by DuPont Pharma under the trade name ReVia and approved for use in the treatment of alcoholism by the Food and Drug Administration (FDA) in January 1995.
New] Innovative Dehumidifier Systems Ron Revia 910-579-3348 ron@innovativedehu.
Results showed that only 23 percent of all patients treated with REVIA relapsed, compared with 54 percent of the placebo-treated patients.